# PediaRounds Master Bank — Shared Progress & Handoff

> **Single source of truth for coordination between ChatGPT conversations.** Read this file and `coordination/current-work-state.md` before work, then update both after every successful batch.

## Repository / active phase
- Repository: `drabdulazizalhazmi-hub/-PediaRounds`
- Base: `main`
- Working branch: `master-bank/review-images-verification`
- Active PR: **#5 — Review images, incomplete recalls, and clinical verification**

## Structural/source milestone
- **1023 records scanned**.
- **1022/1022 enumerated source slots covered; 0 missing**.
- Genetics source anomaly: TOC says 53 but sequence ends at Q52; do not fabricate Q53.
- Exact duplicate IDs: 0; section/Q structural collisions: 0.

## Completed quality work
- Sparse recall: **167/167 directly re-read**.
- Sparse media: **48/48 audited**.
- Outdated queue: **9/9 reviewed**.
- Conflicting queue assignment: **131/131 assigned; 0 unassigned** across three coordinated batches.

## Clinical conflict resolution — underway
Resolution files:
- `review-queue/conflicting-clinical-resolution-batch01-12-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch02-8-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch02-heme-05-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch03-nephro-06-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch04-endo-rheum-02-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch05-7-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch06-12-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch07-6-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch08-12-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch09-11-20260907.json`

### Current-guidance resolution progress
- **81 conflicting records reviewed** in resolution passes.
- **21 clean modern answers** supported by retained stems/options.
- **60 remain non-publishable** because current guidance reveals multiple plausible answers, missing best action/test, insufficient clinical context, missing original media, version-sensitive content, or internally malformed data.
- **0 recalled answers overwritten**.

### Clean modern answers currently supported in review overlays
- Cardiology Q26 → **B, synchronized cardioversion**.
- Cardiology Q27 → **B, synchronized cardioversion**.
- Endocrinology Q55 → **C, both IFG and IGT** under ADA 2026 criteria.
- Hematology Q48 → **D, factor XII deficiency**.
- Hematology Q17 → **D, paroxysmal nocturnal hemoglobinuria**.
- Nephrology/Urology Q62 → **A, testicular torsion** for the retained stem with reduced Doppler perfusion.
- Endocrinology Q15 → **A**, based on current McCune-Albright peripheral-precocious-puberty management framing.
- Rheumatology Q12 → **C, 8,000 WBC with 30% PMN**, best retained fit for inflammatory JIA synovial fluid; not a diagnostic cutoff.
- Hematology Q10 → **A, liver/biliary ultrasound** for acute RUQ pain with bilirubin/liver-test abnormalities in SCD.
- Gastroenterology Q79 → **B, pelvic MRI** among retained options for suspected psoas/pelvic abscess in Crohn disease.
- Gastroenterology Q85 → **B, transabdominal ultrasound** as the recommended initial imaging option when imaging is requested.
- Sleep Q17 → **A, nightmares** based on late-night REM timing.
- Pulmonary Q6 (ABPA) → **D, productive cough with brown mucus plugs** as the strongest current supporting feature among retained choices under revised ISHAM criteria.
- Oncology Q2 (Fanconi anemia) → **D, myelodysplastic syndrome** as the best retained hematologic-risk answer, with major AML risk also acknowledged.
- Endocrinology Q7 → **A, confirm GH-axis diagnosis before committing to GH treatment**; low IGF-1 alone is insufficient.
- Gastroenterology Q57 → **C, CT angiography** as the best retained confirmatory/anatomic study for a suspected vascular ring; source image remains a separate publication gate.
- Growth & Development Q2 → **B, 7 years** for U/L segment ratio approaching 1:1 under current anthropometry references.
- Growth & Development Q6 → **B, 9 months** as the best retained option; CDC 2026 lists sitting without support by 9 months.
- Ophthalmology Q8 → **A, infantile/congenital nystagmus** for onset at four months with normal eye examination and normal MRI.
- Growth & Development Q18 → **C, absent stranger anxiety at 12 months** as the clearly delayed retained social finding under CDC 2026 milestone ages.
- Growth & Development Q21 → **A, language delay** as the best retained diagnosis, with corrected-age and audiology assessment caveats.

### Latest batch09 — 11 reviewed
- Growth Q18 and Q21 were cleanly resolved as above.
- Growth Q15 remains under-supported because the source itself marks the caregiver/calming examination choice uncertain.
- Neonatology Q11 remains invalid because Rh antigen inheritance probability is not hemolytic-disease risk and key sensitization/genotype context is missing.
- Neonatology Q19 remains unresolved because congenital-syphilis treatment depends on a >=30-day maternal-treatment threshold, regimen adequacy, neonatal titers/evaluation, and follow-up; the retained `4 weeks` is 28 days.
- Neonatology Q21 remains invalid as a single-best-answer item because current NIH guidance accepts both HIV RNA and DNA NATs in exposed infants.
- Neonatology Q23 remains context-dependent because persistent candidemia can require fundoscopy, LP, echocardiography and abdominal imaging as part of dissemination evaluation.
- Neonatology Q36 remains non-publishable because the waiter-tip upper-plexus pattern does not justify the retained C5-T1 option as the precise root-level answer.
- Critical Care Q17 remains non-publishable; newer evidence shows factor VIII is not a reliable DIC-versus-liver-disease discriminator and neither retained fibrinogen nor FDP is uniquely reliable.
- Infectious Viral Q13 remains unresolved because EBV itself can cause rash and no amoxicillin exposure was stated.
- Infectious Immunization Q116 remains historical/version-sensitive because the 2020 question does not define which Saudi schedule revisions are being compared.

## Baseline review-status inventory from closure
- `needs_verification`: 585
- `image_missing`: 198
- `image_needs_review`: 10
- `incomplete_recall`: 77
- `conflicting`: 131
- `outdated`: 9
- `deduplicated`: 13

These baseline canonical counts do not automatically decrement merely because a review-overlay file was added; canonical record changes require an explicit safe update pass.

## Coordination protocol
1. GitHub wins over chat memory.
2. Do not repeat completed numbered/source/sparse/media/outdated/conflict-assignment or already committed clinical-resolution work.
3. Keep `recalledAnswer` separate from `verifiedAnswer`.
4. Do not invent missing options, images, calculations, years, stems, or answer keys.
5. Original source images only for source-dependent MCQs.
6. Policy-sensitive Saudi questions require current jurisdictional/institutional references.
7. Source PDFs and secrets must not be committed.

## Highest-priority next work
Continue large clinical conflict-resolution batches through the **remaining 50/131 conflicts not yet resolution-reviewed**, prioritizing complete stems/options in Critical Care, Gastroenterology, Infectious Diseases, Endocrinology, Hematology/Oncology, Genetics, Respiratory, Behavioral/Psychiatry, Neonatology, and other sections. Resolve only where retained choices support a clean current answer; otherwise document why the item remains non-publishable. After conflict-resolution passes, move to large `needs_verification` batches.

---

**Handoff rule:** source coverage is complete; sparse/media/outdated work is complete; all 131 conflicting records are assigned; **81 clinical conflicts have now been resolution-reviewed**, with **21 clean modern answer resolutions** and **60 correctly retained as invalid/under-specified/context-dependent/version-sensitive**.
